NasdaqGS - Nasdaq Real Time Price USD

Biogen Inc. (BIIB)

Compare
205.30 +0.48 (+0.23%)
As of 9:38 AM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
9,672,000.00
9,835,600.00
10,173,400.00
10,981,700.00
13,444,600.00
--
Cost of Revenue
2,366,100.00
2,533,400.00
2,278,300.00
2,109,700.00
1,805,200.00
--
Gross Profit
7,305,900.00
7,302,200.00
7,895,100.00
8,872,000.00
11,639,400.00
--
Operating Expense
5,341,500.00
5,471,100.00
4,993,200.00
6,064,000.00
7,193,100.00
--
Operating Income
1,964,400.00
1,831,100.00
2,901,900.00
2,808,000.00
4,446,300.00
--
Net Non Operating Interest Income Expense
-108,600.00
29,600.00
-157,300.00
-242,600.00
-180,500.00
--
Other Income Expense
-541,900.00
-563,900.00
847,200.00
-820,200.00
781,700.00
--
Pretax Income
1,313,900.00
1,296,800.00
3,591,800.00
1,745,200.00
5,047,500.00
--
Tax Provision
156,300.00
135,300.00
632,800.00
52,500.00
992,300.00
--
Earnings from Equity Interest Net of Tax
--
--
2,600.00
34,900.00
5,300.00
--
Net Income Common Stockholders
1,158,600.00
1,161,100.00
3,046,900.00
1,556,100.00
4,000,600.00
--
Diluted NI Available to Com Stockholders
1,158,600.00
1,161,100.00
3,046,900.00
1,556,100.00
4,000,600.00
--
Basic EPS
7.96
8.02
20.96
10.44
24.86
--
Diluted EPS
7.93
7.97
20.87
10.40
24.80
--
Basic Average Shares
145,100.00
144,700.00
145,300.00
149,100.00
160,900.00
--
Diluted Average Shares
145,850.00
145,600.00
146,000.00
149,600.00
161,300.00
--
Total Operating Income as Reported
--
--
--
2,840,700.00
4,550,100.00
7,042,600.00
Total Expenses
7,707,600.00
8,004,500.00
7,271,500.00
8,173,700.00
8,998,300.00
--
Net Income from Continuing & Discontinued Operation
1,158,600.00
1,161,100.00
3,046,900.00
1,556,100.00
4,000,600.00
--
Normalized Income
1,631,014.28
1,663,218.40
2,340,484.80
2,346,262.00
3,375,223.60
--
Interest Income
157,200.00
276,500.00
89,300.00
11,000.00
42,000.00
--
Interest Expense
265,800.00
246,900.00
246,600.00
253,600.00
222,500.00
--
Net Interest Income
-108,600.00
29,600.00
-157,300.00
-242,600.00
-180,500.00
--
EBIT
1,579,700.00
1,543,700.00
3,838,400.00
1,998,800.00
5,270,000.00
--
EBITDA
2,151,200.00
2,038,500.00
4,356,800.00
2,880,100.00
5,734,800.00
--
Reconciled Cost of Revenue
2,097,300.00
2,279,200.00
2,125,800.00
2,503,300.00
1,812,800.00
--
Reconciled Depreciation
571,500.00
494,800.00
518,400.00
487,700.00
457,200.00
--
Net Income from Continuing Operation Net Minority Interest
1,158,600.00
1,161,100.00
3,046,900.00
1,556,100.00
4,000,600.00
--
Total Unusual Items Excluding Goodwill
-536,200.00
-560,400.00
857,300.00
-814,600.00
778,800.00
--
Total Unusual Items
-536,200.00
-560,400.00
857,300.00
-814,600.00
778,800.00
--
Normalized EBITDA
2,687,400.00
2,598,900.00
3,499,500.00
3,694,700.00
4,956,000.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-63,785.72
-58,281.60
150,884.80
-24,438.00
153,423.60
--
12/31/2019 - 9/17/1991

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers